NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
OHSU Knight Cancer Institute
The University of Texas Health Science Center at San Antonio
Oncolytics Biotech
Universitaire Ziekenhuizen KU Leuven
Vanderbilt-Ingram Cancer Center